Dietary Magnesium Intake and Metabolic Syndrome in the Adult Population: Dose-Response Meta-Analysis and Meta-Regression

Nutrients
Q1
Dec 2014
Citations:61
Influential Citations:2
Systematic Reviews / Meta-Analyses
85
S2 IconPDF Icon

Enhanced Details

Methods
Meta-analysis of observational studies (10 articles: 8 cross-sectional, 2 prospective cohorts) including 30,092 participants. Adults aged 18–72 from population-based and hospital-based settings (including elderly type 2 diabetes patients and kidney transplant recipients). Dietary magnesium intake assessed by FFQ, 24-hour recalls, or a 3-day dietary record; metabolic syndrome defined by ATP-III or modified ATP-III/IDF criteria; no randomized trials included.
Results
Dietary magnesium intake is inversely associated with metabolic syndrome. The pooled RR for a 150 mg/day increase is 0.88 (95% CI 0.84-0.93) with moderate heterogeneity (I2 = 36.3%). The relationship appears linear across intake levels, with higher magnesium intake linked to lower metabolic syndrome risk. Authors suggest focusing on magnesium-rich foods rather than supplements and call for longitudinal studies and randomized trials to establish causality and evaluate supplementation.
Limitations
Moderate heterogeneity across studies (I2 36.3%); variability in dietary magnesium assessment methods (FFQ, 24-hour recalls, and 3-day records); residual confounding inherent to observational designs; exposure measured primarily at baseline; data for higher intake levels (>450 mg/day) were sparse; cannot assess effects of magnesium supplements.

Abstract

Increasing evidence has suggested an association between dietary magnesium intake and metabolic syndrome. However, previous research examining dietary magnesium intake and metabolic syndrome has produced mixed results. Our objective was to determine ...